Cannabis and Medical Research

The conversation highlights the complexities of cannabis as a treatment option, particularly for challenging conditions like glioblastoma. Researchers emphasize the potential of cannabinoids to impact tumor progression, yet face significant hurdles due to federal regulations that classify cannabis as a Schedule I substance. This legal status complicates research efforts and public understanding of its medical value.